Pharma Journalist - Page 66 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

FDA Grants Priority Review to Gepotidacin for Oral Treatment of Gonorrhea

Sartorius Stedim Biotech and Nanotein Partner to Boost Cell Therapy Manufacturing

FDA Accepts Arvinas’ NDA for Vepdegestrant in ER+/HER2- Breast Cancer with ESR1 Mutation

Ono and Seikagaku Partner to Co-Develop and Market Gel-One for Osteoarthritis in Japan

CorMedix to Acquire Melinta, Expanding Acute Care Portfolio

Valneva: FDA Lifts Pause on IXCHIQ for Elderly, Updates Prescribing Info

Genmab’s EPCORE FL-1 Trial Meets Goals in R/R FL

Cingulate Files FDA New Drug Application for Lead ADHD Drug CTx-1301

Fresenius, Polpharma Biologics Ink Deal to Commercialize Vedolizumab Biosimilar

FDA Expands Approval of AJOVY as First Anti-CGRP Preventive for Pediatric Episodic Migraine